Mark Emberton is a Professor of Interventional Oncology at UCL and Honorary Consultant Urologist at University College Hospitals NHS Foundation Trust (UCLH), where he leads an internationally recognised research group which looks at better diagnosis and treatment for men with prostate cancer. In August 2015 he was appointed as Dean of the Faculty of Medical Sciences at UCL.
Mark has published over 300 scientific papers, lectures internationally and is a sought after visiting professor. He was awarded NIHR Senior Investigator status in 2015. He is a founding member of the pioneer programme of Prostate Cancer UK.